Notice of Closed Meeting, 2618 [2024-00676]
Download as PDF
<![CDATA[
2618
Federal Register / Vol. 89, No. 10 / Tuesday, January 16, 2024 / Notices
data, training screeners, conducting the
oral health screening at schools or Head
Start sites. Screeners record four data
points either electronically or on a
paper form: (1) presence of treated
caries; (2) presence of untreated tooth
decay; (3) urgency of need for treatment;
and (4) presence of dental sealants on at
least one permanent molar tooth.
State programs enter, clean and
analyze the data; de-identify it; and
respond to ASTDD’s annual email
request for State-aggregated prevalence
of dental caries and sealants. ASTDD
reviews the data to ensure that both
survey design and data meet specific
criteria before sending it to CDC for
publication on the CDC’s public-facing
Oral Health Data website (www.cdc.gov/
oralhealthdata).
BSS for children serves as a key State
oral health surveillance data source and
facilitates State capacity to: (1) monitor
children’s oral health status, trends, and
disparities, and compare with other
States; (2) inform planning,
implementation and evaluation of
effective oral health programs and
policies; (3) measure State progress
toward Healthy People objectives; and
(4) educate the public and policy
makers regarding cross-cutting public
health programs. CDC also uses the data
to evaluate performance of CDC oral
health funding recipients.
The estimated total annualized
burden hours for the survey across the
34 States over the three years of this
request are 40,207. There are no costs to
children respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Form name
Child .....................................
Parent/caretaker ..................
Screener ..............................
School/site ...........................
State Official ........................
Screening form ................................................
Consent ...........................................................
Screening form ................................................
Participation form ............................................
Data Submission form .....................................
150,370
150,370
301
2,890
34
1
1
1
1
1
5/60
1/60
666/60
68/60
32,742/60
12,531
2,506
3,341
3,275
18,554
Total ..............................
..........................................................................
........................
........................
......................
40,207
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–00654 Filed 1–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
respondents
Type of respondents
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)–RFA–PS–24–039
Improving the Quality of Life of People with
VerDate Sep<11>2014
18:57 Jan 12, 2024
Jkt 262001
HIV Aged 50 Years and Older in the United
States, and RFA–PS–24–042 A Bridge to
Adherence: Long-Acting Antiretroviral
Therapy for People with HIV Released from
Prison.
Dates: May 1–2, 2024.
Times: 10 a.m.–5 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Seraphine Pitt Barnes, Ph.D., M.P.H,
C.H.E.S., Scientific Review Officer, National
Center for HIV, Viral Hepatitis, STD, and TB
Prevention, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop
H24–6, Atlanta, Georgia 30329–4027.
Telephone: (770) 488–6115; Email:
SPittBarnes@cdc.gov.
The Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, has been delegated the authority
to sign Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–00676 Filed 1–12–24; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel; (SEP)–RFA–IP–24–046,
Nationwide Cohort to Estimate Burden of
Respiratory Viruses and Immunologic
Response (Blood Donor Cohort).
Dates: April 11–12, 2024.
Times: 10 a.m.–5 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Gregory
Anderson, M.S., M.P.H, Scientific Review
Officer, National Center for HIV, Viral
E:\FR\FM\16JAN1.SGM
16JAN1
]]>Agencies
[Federal Register Volume 89, Number 10 (Tuesday, January 16, 2024)]
[Notices]
[Page 2618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00676]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)-RFA-PS-24-039 Improving the
Quality of Life of People with HIV Aged 50 Years and Older in the
United States, and RFA-PS-24-042 A Bridge to Adherence: Long-Acting
Antiretroviral Therapy for People with HIV Released from Prison.
Dates: May 1-2, 2024.
Times: 10 a.m.-5 p.m., EDT.
Place: Videoconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Seraphine Pitt Barnes, Ph.D.,
M.P.H, C.H.E.S., Scientific Review Officer, National Center for HIV,
Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, Mailstop H24-6, Atlanta,
Georgia 30329-4027. Telephone: (770) 488-6115; Email:
[email protected].
The Director, Office of Strategic Business Initiatives, Office
of the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal
Register notices pertaining to announcements of meetings and other
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and
Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-00676 Filed 1-12-24; 8:45 am]
BILLING CODE 4163-18-P
